Impact of Shenfu injection on a composite of organ dysfunction development in critically ill patients with coronavirus disease 2019 (COVID-19): A structured summary of a study protocol for a randomized controlled trial
Letter
[키워드] 1:1
28-day mortality
48 hours
adopted
allergic
allergy
allocation concealment
alveolar
baseline
bleeding
blinded
Blinding
block randomization
both group
breastfeeding women
caused
China
Chinese
clinical
clinical trial
conducted
control group
coronavirus disease
COVID-19
criteria
Critical
Critically ill patient
death
defined
determine
Diagnosis
dissemination
distribution
element
enrolled
enrolment
event
exacerbated
expected
HIV
hospital
hospital cost
ICU
immunosuppressive drug
Impact
incidence
include
increase in
injection
intensive care
Length
lung
malignant tumor
management guideline
multicenter
National Health Commission
number
objective
Obstructive
Open-label
organ
organ dysfunction
Organ failure
outcome
parallel group
participant
Patient
patient recruitment
patients
patients with COVID-19
Pneumonia
pregnant
primary endpoint
protocol
provided
pulmonary interstitial fibrosis
random
randomised
randomised controlled trial
randomization
Randomized
Randomized controlled trial
Randomly
receive
recruit
recruited
researchers
Sample size
SAS
sealed
secondary endpoint
Sepsis
Seven
severe malnutrition
severity
Shenfu injection
shown
SOFA
SOFA score
statistical
status
study group
Study protocol
supportive therapy
the patient
Total
treat
Treatment
Two-arm
underlying disease
usual care
vasoactive drug
Volume
website
[DOI] 10.1186/s13063-020-04677-5 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04677-5 PMC 바로가기 [Article Type] Letter